Clinical Trials in Bad Krozingen, Germany
5 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Boehringer Ingelheim4,200 enrolled641 locationsNCT06935370
Recruiting
A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis
Multiple Sclerosis
Novartis Pharmaceuticals700 enrolled108 locationsNCT06551519
Recruiting
The ReTAVI Prospective Observational Registry
Structural Valve DeteriorationStructural Valve DegenerationSymptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure+2 more
Institut für Pharmakologie und Präventive Medizin250 enrolled62 locationsNCT05601453
Recruiting
The "Global Paradise System" Registry
Hypertension
ReCor Medical, Inc.3,000 enrolled35 locationsNCT05027685